Designing CAR T cell therapy for HIV Cure studies
James L. Riley, Ph.D., Professor of Microbiology, Perelman School of Medicine- University of Pennsylvania
James L. Riley, Ph.D., Professor of Microbiology, Perelman School of Medicine- University of Pennsylvania
Peter W. Hunt, M.D., Professor, Division of Experimental Medicine, Department of Medicine- University of California San Francisco; Co-Director of the UCSF-Bay Area CFAR for Basic and Translational Science
Mary Carrington, Ph.D., Director, Basic Science Program, Frederick National Laboratory for Cancer Research, Laboratory of Integrative Cancer Immunology- National Cancer Institute
Pei-Yong Shi, Ph.D., John Sealy Distinguished Chair in Innovations in Molecular Biology, Vice Chair for Innovation and Commercialization, Department of Biochemistry & Molecular Biology- University of Texas Medical Branch at Galveston
C. Sabrina Tan, M.D., Principal Investigator and CTU Principal Investigator, CVVR- Assistant Professor of Medicine, Harvard Medical School, Staff Physician, Division of Infectious Diseases, BIDMC
Robert Flaumenhaft- BIDMC
Robert Flaumenhaft, M.D., Ph.D., Professor of Medicine, Chief, Division of Hemostasis and Thrombosis, BIDMC- Harvard Medical School
Klaus Frueh, Ph.D., Professor, Vaccine and Gene Therapy Institute, Oregon Health and Science University
Ai-Ris Collier, M.D., Maternal-Fetal Medicine, BIDMC, Instructor in Obstetrics, Gynecology, and Reproductive Biology at HMS, Physician-Scientist in CVVR
Emilia Liana Falcone, M.D., Ph.D., FRCPC